HealthyNCT07667699
Multidimensional Determinants of Functional Health In Women Aged 45-60
An observational study of Healthy and Perimenopausal Depression, run by Kartal City Hospital at 1 site in Turkey (Türkiye).
Trial summary
The goal of this observational study is to learn about the multidimensional determinants of functional health in women aged 45 to 60 years. The study will focus on the role of muscle strength, bone mineral density, body composition, physical activity, sleep quality, depressive symptoms, and menopause-related symptoms… Read more about this study
- Who is it for?
- Ages 45 to 60 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Healthy, Perimenopausal Depression, Menopausal Complaints
- How many people
- 200 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 1 Jul 2026to 31 Dec 2026
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 45 to 60 years
- Women only
- Healthy volunteers accepted
- Adult
Study population: The study population will be drawn from women attending the Obstetrics and Gynecology outpatient clinic of Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey. Participants will be identified among patients presenting for routine outpatient gynecologic care and will undergo study-specific assessments during a single outpatient visit.
Who may be able to join
- Women aged 45 to 60 years
- Ability to read and complete study questionnaires
- Provision of written informed consent
- Ability to complete physical performance assessments
Who cannot join
- Acute systemic illness
- Active malignancy
- Severe neurological or orthopedic impairment limiting physical performance assessment
- Cognitive impairment precluding informed consent or questionnaire completion
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)1 site
Kartal Dr Lütfi Kırdar Şehir Hastanesi
Istanbul, Türkiye
About this study
Official title: Multidimensional Determinants and Structural Foundations of Functional Health In Women Aged 45-60: The Role of Muscle and Bone Health
The goal of this observational study is to learn about the multidimensional determinants of functional health in women aged 45 to 60 years. The study will focus on the role of muscle strength, bone mineral density, body composition, physical activity, sleep quality, depressive symptoms, and menopause-related symptoms in functional health.
The main questions it aims to answer are:
Read more
- Does muscle strength contribute to functional health in women aged 45 to 60 years?
- Does bone mineral density contribute to functional health in women aged 45 to 60 years?
- How are physical activity, sleep quality, depressive symptoms, body composition, and menopause-related quality of life associated with functional health?
Participants will:
- Undergo handgrip strength measurement
- Perform a 30-second chair stand test
- Undergo bone mineral density and body composition assessment
- Complete questionnaires about physical activity, sleep quality, depressive symptoms, menopausal symptoms, and quality of life
- Provide demographic and clinical information
Read the detailed description
This is a single-center, cross-sectional observational study designed to evaluate the multidimensional determinants of functional health in women aged 45 to 60 years. The study will be conducted at the Department of Obstetrics and Gynecology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey.
Midlife and the menopausal transition are associated with changes in muscle strength, bone mineral density, body composition, metabolic profile, physical performance, sleep quality, mood, and menopause-related symptoms. Functional health is a multidimensional construct encompassing physical capacity, independence in daily activities, psychological well-being, and health-related quality of life. This study will assess functional health using biological, behavioral, psychological, and symptom-related indicators rather than relying on a single test or questionnaire score.
Inclusion Criteria are:
- Women aged 45 to 60 years
- Ability to read and complete study questionnaires
- Provision of written informed consent
- Ability to complete physical performance assessments
Exclusion Criteria are:
- Acute systemic illness
- Active malignancy
- Severe neurological or orthopedic impairment limiting physical performance assessment
- Cognitive impairment precluding informed consent or questionnaire completion Eligible participants will be evaluated during a single outpatient visit. After written informed consent is obtained, demographic and clinical data will be recorded. These data will include age, marital status, obstetric history, socioeconomic status, menopausal status and duration, body mass index, comorbidities, medication use, and lifestyle characteristics.
Muscle strength and physical performance will be assessed using handgrip strength measurement with a dynamometer and the 30-second chair stand test. Anthropometric measurements, including body weight and waist circumference, will be obtained. Body composition will be assessed using a bioelectrical impedance analysis device.
Bone health will be evaluated using dual-energy X-ray absorptiometry data. Existing bone mineral density data obtained within the previous 6 months will be used, and no repeat DXA assessment will be carried out. Laboratory parameters include complete blood count, 25-hydroxyvitamin D, vitamin B12, ferritin, liver function tests, lipid profile, glucose-related parameters, HbA1c, and/or HOMA-IR.
Participants will complete validated questionnaires assessing physical activity, vulvovaginal symptoms, menopausal symptoms, menopause-specific quality of life, general health-related quality of life, depressive symptoms, and sleep quality. The questionnaires planned for use include the International Physical Activity Questionnaire-Short Form, Vulvovaginal Symptoms Questionnaire, Menopause Rating Scale, Menopause-Specific Quality of Life Questionnaire-II, SF-36 Health Survey, Beck Depression Inventory, and Pittsburgh Sleep Quality Index.
Data will be collected using standardized case report forms. Questionnaire forms will be provided by the principal investigator and completed by the participants during the study visit. Physical performance tests will be performed in the outpatient clinic by the principal investigator. Body composition measurements will be performed by the co-investigator.
Data quality will be supported by predefined study variables, standardized data-collection forms, and consistency checks during data entry. The database will be reviewed for missing, out-of-range, or inconsistent values. When a variable is unavailable in the medical record, it will be coded as missing. No imputation is planned for unavailable variables; analyses will be conducted using available data, and the number of participants included in each analysis will be reported.
Approximately 200 women are planned for inclusion. This sample size was selected to allow multivariable analyses and structural equation modeling. The planned model is expected to include approximately 15 to 20 observed variables and 20 to 25 free parameters. A minimum sample size of approximately 180 participants was estimated based on the recommended ratio of participants to free parameters in structural equation modeling. Therefore, enrollment of at least 200 participants is planned to improve model stability and allow reliable estimation of model fit indices.
Descriptive statistics will be used to summarize demographic, clinical, functional, densitometric, laboratory, and questionnaire-based variables. Associations between variables will be evaluated using correlation analyses and multivariable regression models. Age, body mass index, menopausal duration, and comorbidities will be considered as covariates. Statistical significance will be set at p < 0.05. Structural equation modeling will be used to examine the structural relationships among muscle health, bone health, body composition, physical activity, sleep quality, depressive symptoms, menopausal symptoms, and functional health.
The study is expected to provide a multidimensional model of functional health in women aged 45 to 60 years and to clarify the independent contribution of muscle and bone health to functional capacity and health-related quality of life during midlife.
- Conditions
- Healthy, Perimenopausal Depression, Menopausal Complaints, Bone Mineral Density, Sarcopenia, Sleep Quality
- Keywords
- Menopause, Perimenopause, Bone mineral density, Sarcopenia, Sleep Quality, Quality of life
- Medical subject headings
- Sarcopenia, Sleep Initiation and Maintenance Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
Physical Functional Performance Score assessed by 30-Second Chair Stand Test and Hand-Grip Dynamometry (composite z-score)
Functional performance will be operationalised as a composite of two validated measures: (1) number of repetitions completed in the 30-second chair stand test as a measure of lower extremity strength, and (2) dominant hand grip strength (kg) will be measured by calibrated hydraulic hand dynamometer following EWGSOP2 protocol. A standardised composite functional performance z-score will be derived by summing the z-scores of both measures. The primary analysis will examine the independent contributions of bone mineral density and skeletal muscle mass to this composite score using multivariable linear regression and structural equation modelling (SEM).
Measured: Baseline
Secondary outcomes (14)
Bone Mineral Density measured by DXA (g/cm²)
Lumbar spine (L1-L4) and Femoral neck areal BMD (g/cm²) will be measured by dual-energy X-ray absorptiometry (DXA). The values will be compared across three age subgroups (45-50, 50-55, 55-60 years).
Measured: Baseline
Hand-Grip Strength measured by hydraulic hand dynamometer (kg)
Dominant hand grip strength (kg) will be measured by calibrated hydraulic hand dynamometer following EWGSOP2 protocol. Among the three trials performed; mean value will be recorded.
Measured: Baseline
Lower Extremity Functional Strength assessed by 30-Second Chair Stand Test (number of repetitions)
Number of full sit-to-stand repetitions completed within 30 seconds without arm support, following standardised protocol.
Measured: Baseline
Total Body Fat Mass measured by BIA (kg)
Total body fat mass (kg) assessed by bioelectrical impedance analysis (BIA).
Measured: Baseline
Total Body Fat Percentage measured by BIA (%)
Total body fat percentage (%) assessed by bioelectrical impedance analysis (BIA).
Measured: Baseline
Fat-Free Mass measured by BIA (kg)
Total fat-free mass (kg) assessed by bioelectrical impedance analysis (BIA).
Measured: Baseline
Skeletal Muscle Mass measured by BIA (kg)
Appendicular and total skeletal muscle mass (kg) assessed by bioelectrical impedance analysis (BIA).
Measured: Baseline
Total Body Water measured by BIA (litres)
Total body water (litres) assessed by bioelectrical impedance analysis (BIA).
Measured: Baseline
Body Mass Index (BMI) calculated from measured height and weight (kg/m²)
Body weight (kg) and height (cm) is measured by standardised anthropometry; BMI will be calculated as weight divided by height squared (kg/m²).
Measured: Baseline
Physical Component Summary Score of SF-36 (units on a scale 0-100)
Physical Component Summary (PCS) score derived from the validated Turkish version of the Short Form-36 (SF-36) questionnaire. Score range 0-100; higher scores indicate better physical health-related quality of life.
Measured: Baseline
Mental Component Summary Score of SF-36 (units on a scale 0-100)
Mental Component Summary (MCS) score derived from the validated Turkish version of the SF-36. Score range 0-100; higher scores indicate better mental health-related quality of life.
Measured: Baseline
Menopause-Specific Quality of Life (MENQOL) Total Score (units on a scale 1-8)
Total score from the validated Turkish version of the Menopause-Specific Quality of Life Questionnaire (MENQOL), a 29-item instrument. Score range 1-8 per item; higher scores indicate greater symptom burden across vasomotor, psychosocial, physical, and sexual domains.
Measured: Baseline
Global Sleep Quality Score assessed by Pittsburgh Sleep Quality Index - PSQI (units on a scale 0-21)
Global PSQI score from the validated Turkish version of the Pittsburgh Sleep Quality Index. Score range 0-21; scores above 5 indicate poor sleep quality.
Measured: Baseline
Physical Activity Level assessed by IPAQ-Short Form (MET-minutes per week)
Total weekly physical activity expressed as metabolic equivalent of task minutes per week (MET-min/week), calculated from the validated Turkish version of the International Physical Activity Questionnaire - Short Form (IPAQ-SF).
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Jun 2026
- Study start1 Jul 2026
- Primary completion31 Dec 2026 (estimated)
- Study completion31 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (4)Papers the sponsor has linked to this study.
- Other trials for HealthyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 200 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Kartal City Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Elif Unlugedik Sayin, Kartal City Hospital
- Investigators
- Elif Unlugedik Sayın, MD, PhD, Principal investigator, University of Health Sciences, Kartal Dr Lütfi Kırdar City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07667699
- Sponsor's protocol ID
- 2026/010.99/26/11
- Status last verified
- Oct 2026
- First submitted
- 8 Jun 2026
- Last updated
- 14 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: The decision to share individual participant data has not yet been finalized. The study includes clinical, questionnaire-based, functional, densitometric, and laboratory data obtained from outpatient assessments and hospital records. Any future data sharing would be limited to de-identified data and would require appropriate ethical and institutional approval.
Publications
Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, McCloskey EV, Kanis JA. Osteoporosis and fractures in women: the burden of disease. Climacteric. 2022 Feb;25(1):4-10. doi: 10.1080/13697137.2021.1951206. Epub 2021 Jul 28.
PubMed 34319208Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13.
PubMed 25982160Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.
PubMed 10380242Geraldi MV, Brattemark E, Lorentzon M. Longitudinal associations of dietary intake, physical activity, and short-chain fatty acids with bone development in early postmenopausal women. Osteoporos Int. 2026 Apr;37(4):879-892. doi: 10.1007/s00198-026-07861-6. Epub 2026 Feb 2.
PubMed 41622331
Study at a glance
From the registry record, last updated by the sponsor on 14 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multidimensional Determinants and Structural Foundations of Functional Health In Women Aged 45-60: The Role of Muscle and Bone Health
- ClinicalTrials.gov ID
- NCT07667699
- Acronym / sponsor ID
- 2026/010.99/26/11
- Conditions
- Healthy, Perimenopausal Depression, Menopausal Complaints, Bone Mineral Density, Sarcopenia, Sleep Quality
- Keywords
- Menopause, Perimenopause, Bone mineral density, Sarcopenia, Sleep Quality, Quality of life
- Study type
- Observational
- Recruitment status
- Enrolling by invitation
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Kartal City HospitalUniversity, hospital or other
- Study start
- 1 Jul 2026 (actual)
- Primary completion
- 31 Dec 2026 (estimated)
- Study completion
- 31 Dec 2026 (estimated)
- First posted
- 25 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn about the multidimensional determinants of functional health in women aged 45 to 60 years. The study will focus on the role of muscle strength, bone mineral density, body composition, physical activity, sleep quality, depressive symptoms, and menopause-related symptoms in functional health.
The main questions it aims to answer are:
- Does muscle strength contribute to functional health in women aged 45 to 60 years?
- Does bone mineral density contribute to functional health in women aged 45 to 60 years?
- How are physical activity, sleep quality, depressive symptoms, body composition, and menopause-related quality of life associated with functional health?
Participants will:
- Undergo handgrip strength measurement
- Perform a 30-second chair stand test
- Undergo bone mineral density and body composition assessment
- Complete questionnaires about physical activity, sleep quality, depressive symptoms, menopausal symptoms, and quality of life
- Provide demographic and clinical information
Detailed description
This is a single-center, cross-sectional observational study designed to evaluate the multidimensional determinants of functional health in women aged 45 to 60 years. The study will be conducted at the Department of Obstetrics and Gynecology, Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey.
Midlife and the menopausal transition are associated with changes in muscle strength, bone mineral density, body composition, metabolic profile, physical performance, sleep quality, mood, and menopause-related symptoms. Functional health is a multidimensional construct encompassing physical capacity, independence in daily activities, psychological well-being, and health-related quality of life. This study will assess functional health using biological, behavioral, psychological, and symptom-related indicators rather than relying on a single test or questionnaire score.
Inclusion Criteria are:
- Women aged 45 to 60 years
- Ability to read and complete study questionnaires
- Provision of written informed consent
- Ability to complete physical performance assessments
Exclusion Criteria are:
- Acute systemic illness
- Active malignancy
- Severe neurological or orthopedic impairment limiting physical performance assessment
- Cognitive impairment precluding informed consent or questionnaire completion Eligible participants will be evaluated during a single outpatient visit. After written informed consent is obtained, demographic and clinical data will be recorded. These data will include age, marital status, obstetric history, socioeconomic status, menopausal status and duration, body mass index, comorbidities, medication use, and lifestyle characteristics.
Muscle strength and physical performance will be assessed using handgrip strength measurement with a dynamometer and the 30-second chair stand test. Anthropometric measurements, including body weight and waist circumference, will be obtained. Body composition will be assessed using a bioelectrical impedance analysis device.
Bone health will be evaluated using dual-energy X-ray absorptiometry data. Existing bone mineral density data obtained within the previous 6 months will be used, and no repeat DXA assessment will be carried out. Laboratory parameters include complete blood count, 25-hydroxyvitamin D, vitamin B12, ferritin, liver function tests, lipid profile, glucose-related parameters, HbA1c, and/or HOMA-IR.
Participants will complete validated questionnaires assessing physical activity, vulvovaginal symptoms, menopausal symptoms, menopause-specific quality of life, general health-related quality of life, depressive symptoms, and sleep quality. The questionnaires planned for use include the International Physical Activity Questionnaire-Short Form, Vulvovaginal Symptoms Questionnaire, Menopause Rating Scale, Menopause-Specific Quality of Life Questionnaire-II, SF-36 Health Survey, Beck Depression Inventory, and Pittsburgh Sleep Quality Index.
Data will be collected using standardized case report forms. Questionnaire forms will be provided by the principal investigator and completed by the participants during the study visit. Physical performance tests will be performed in the outpatient clinic by the principal investigator. Body composition measurements will be performed by the co-investigator.
Data quality will be supported by predefined study variables, standardized data-collection forms, and consistency checks during data entry. The database will be reviewed for missing, out-of-range, or inconsistent values. When a variable is unavailable in the medical record, it will be coded as missing. No imputation is planned for unavailable variables; analyses will be conducted using available data, and the number of participants included in each analysis will be reported.
Approximately 200 women are planned for inclusion. This sample size was selected to allow multivariable analyses and structural equation modeling. The planned model is expected to include approximately 15 to 20 observed variables and 20 to 25 free parameters. A minimum sample size of approximately 180 participants was estimated based on the recommended ratio of participants to free parameters in structural equation modeling. Therefore, enrollment of at least 200 participants is planned to improve model stability and allow reliable estimation of model fit indices.
Descriptive statistics will be used to summarize demographic, clinical, functional, densitometric, laboratory, and questionnaire-based variables. Associations between variables will be evaluated using correlation analyses and multivariable regression models. Age, body mass index, menopausal duration, and comorbidities will be considered as covariates. Statistical significance will be set at p < 0.05. Structural equation modeling will be used to examine the structural relationships among muscle health, bone health, body composition, physical activity, sleep quality, depressive symptoms, menopausal symptoms, and functional health.
The study is expected to provide a multidimensional model of functional health in women aged 45 to 60 years and to clarify the independent contribution of muscle and bone health to functional capacity and health-related quality of life during midlife.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 45 to 60 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
- Study population
- The study population will be drawn from women attending the Obstetrics and Gynecology outpatient clinic of Kartal Dr. Lütfi Kırdar City Hospital, Istanbul, Turkey. Participants will be identified among patients presenting for routine outpatient gynecologic care and will undergo study-specific assessments during a single outpatient visit.
Key inclusion criteria (4 listed)
- Women aged 45 to 60 years
- Ability to read and complete study questionnaires
- Provision of written informed consent
- Ability to complete physical performance assessments
Key exclusion criteria (4 listed)
- Acute systemic illness
- Active malignancy
- Severe neurological or orthopedic impairment limiting physical performance assessment
- Cognitive impairment precluding informed consent or questionnaire completion
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Physical Functional Performance Score assessed by 30-Second Chair Stand Test and Hand-Grip Dynamometry (composite z-score)
Time frame: Baseline
Functional performance will be operationalised as a composite of two validated measures: (1) number of repetitions completed in the 30-second chair stand test as a measure of lower extremity strength, and (2) dominant hand grip strength (kg) will be measured by calibrated hydraulic hand dynamometer following EWGSOP2 protocol. A standardised composite functional performance z-score will be derived by summing the z-scores of both measures. The primary analysis will examine the independent contributions of bone mineral density and skeletal muscle mass to this composite score using multivariable linear regression and structural equation modelling (SEM).
14 secondary outcomes
Bone Mineral Density measured by DXA (g/cm²)
Time frame: Baseline
Hand-Grip Strength measured by hydraulic hand dynamometer (kg)
Time frame: Baseline
Lower Extremity Functional Strength assessed by 30-Second Chair Stand Test (number of repetitions)
Time frame: Baseline
Total Body Fat Mass measured by BIA (kg)
Time frame: Baseline
Total Body Fat Percentage measured by BIA (%)
Time frame: Baseline
Fat-Free Mass measured by BIA (kg)
Time frame: Baseline
Skeletal Muscle Mass measured by BIA (kg)
Time frame: Baseline
Total Body Water measured by BIA (litres)
Time frame: Baseline
Body Mass Index (BMI) calculated from measured height and weight (kg/m²)
Time frame: Baseline
Physical Component Summary Score of SF-36 (units on a scale 0-100)
Time frame: Baseline
Mental Component Summary Score of SF-36 (units on a scale 0-100)
Time frame: Baseline
Menopause-Specific Quality of Life (MENQOL) Total Score (units on a scale 1-8)
Time frame: Baseline
Global Sleep Quality Score assessed by Pittsburgh Sleep Quality Index - PSQI (units on a scale 0-21)
Time frame: Baseline
Physical Activity Level assessed by IPAQ-Short Form (MET-minutes per week)
Time frame: Baseline
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Oct 2026.
- Background: PubMed 34319208Lorentzon M, Johansson H, Harvey NC, Liu E, Vandenput L, McCloskey EV, Kanis JA. Osteoporosis and fractures in women: the burden of disease. Climacteric. 2022 Feb;25(1):4-10. doi: 10.1080/13697137.2021.1951206. Epub 2021 Jul 28.
- Background: PubMed 25982160Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, Seron P, Ahmed SH, Rosengren A, Kelishadi R, Rahman O, Swaminathan S, Iqbal R, Gupta R, Lear SA, Oguz A, Yusoff K, Zatonska K, Chifamba J, Igumbor E, Mohan V, Anjana RM, Gu H, Li W, Yusuf S; Prospective Urban Rural Epidemiology (PURE) Study investigators. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015 Jul 18;386(9990):266-73. doi: 10.1016/S0140-6736(14)62000-6. Epub 2015 May 13.
- Background: PubMed 10380242Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999 Jun;70(2):113-9. doi: 10.1080/02701367.1999.10608028.
- Background: PubMed 41622331Geraldi MV, Brattemark E, Lorentzon M. Longitudinal associations of dietary intake, physical activity, and short-chain fatty acids with bone development in early postmenopausal women. Osteoporos Int. 2026 Apr;37(4):879-892. doi: 10.1007/s00198-026-07861-6. Epub 2026 Feb 2.
- Individual participant dataSharing planned: Undecided. The decision to share individual participant data has not yet been finalized. The study includes clinical, questionnaire-based, functional, densitometric, and laboratory data obtained from outpatient assessments and hospital records. Any future data sharing would be limited to de-identified data and would require appropriate ethical and institutional approval.
Related trials for Healthy
Recruiting
THE EFFECTS OF GAME-BASED EXERCISE PROGRAMS
Physical Activity, Body Image
Not yet recruitingPhase 1
A Phase I Study of GLR2053 Tablets in Chinese Healthy Adult Participants
Atopic Dermatitis
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Neuroergonomic Analysis of a Brain-Computer Interface Device (BCI)
Healthy Volunteers - Male and Female
RecruitingPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Healthy Volunteer, Atopic Dermatitis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Elif Unlugedik Sayın, MD, PhD principal investigator
University of Health Sciences, Kartal Dr Lütfi Kırdar City Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Healthy and Perimenopausal Depression, run by Kartal City Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 14 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Physical Functional Performance Score assessed by 30-Second Chair Stand Test and Hand-Grip Dynamometry (composite z-score) (time frame: Baseline). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07667699, which also lists 4 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Oct 2026.